| Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy C Sanmartín, D Plano, AK Sharma, JA Palop International journal of molecular sciences 13 (8), 9649-9672, 2012 | 273 | 2012 |
| Selenocyanates and diselenides: a new class of potent antileishmanial agents D Plano, Y Baquedano, D Moreno-Mateos, M Font, A Jiménez-Ruiz, ... European journal of medicinal chemistry 46 (8), 3315-3323, 2011 | 157 | 2011 |
| Design, synthesis, and biological evaluation of novel selenium (Se-NSAID) molecules as anticancer agents D Plano, DN Karelia, MK Pandey, JE Spallholz, S Amin, AK Sharma Journal of medicinal chemistry 59 (5), 1946-1959, 2016 | 155 | 2016 |
| Selenium and clinical trials: new therapeutic evidence for multiple diseases C Sanmartín, D Plano, M Font, JA Palop Current medicinal chemistry 18 (30), 4635-4650, 2011 | 129 | 2011 |
| Selenium compounds and apoptotic modulation: a new perspective in cancer therapy C Sanmartin, D Plano, JA Palop Mini reviews in medicinal chemistry 8 (10), 1020-1031, 2008 | 124 | 2008 |
| Antioxidant-prooxidant properties of a new organoselenium compound library D Plano, Y Baquedano, E Ibáñez, I Jiménez, JA Palop, JE Spallholz, ... Molecules 15 (10), 7292-7312, 2010 | 115 | 2010 |
| Synthesis and antiproliferative activity of novel selenoester derivatives E Domínguez-Álvarez, D Plano, M Font, A Calvo, C Prior, C Jacob, ... European journal of medicinal chemistry 73, 153-166, 2014 | 107 | 2014 |
| Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors: Miniperspective D Plano, S Amin, AK Sharma Journal of medicinal chemistry 57 (13), 5509-5524, 2014 | 102 | 2014 |
| Sulfur and selenium derivatives of quinazoline and pyrido [2, 3-d] pyrimidine: synthesis and study of their potential cytotoxic activity in vitro E Moreno, D Plano, I Lamberto, M Font, I Encío, JA Palop, C Sanmartín European journal of medicinal chemistry 47, 283-298, 2012 | 102 | 2012 |
| Development and therapeutic potential of selenazo compounds AC Ruberte, C Sanmartin, C Aydillo, AK Sharma, D Plano Journal of Medicinal Chemistry 63 (4), 1473-1489, 2019 | 94 | 2019 |
| Novel heteroaryl selenocyanates and diselenides as potent antileishmanial agents Y Baquedano, V Alcolea, MÁ Toro, KJ Gutiérrez, P Nguewa, M Font, ... Antimicrobial agents and chemotherapy 60 (6), 3802-3812, 2016 | 78 | 2016 |
| Synthesis and antiproliferative activity of novel symmetrical alkylthio-and alkylseleno-imidocarbamates E Ibáñez, D Plano, M Font, A Calvo, C Prior, JA Palop, C Sanmartín European journal of medicinal chemistry 46 (1), 265-274, 2011 | 77 | 2011 |
| Synthesis and in vitro Anticancer Activities of some Selenadiazole Derivatives D Plano, E Moreno, M Font, I Encio, JA Palop, C Sanmartin Archiv der Pharmazie 343 (11‐12), 680-691, 2010 | 77 | 2010 |
| Synthesis and pharmacological screening of several aroyl and heteroaroyl selenylacetic acid derivatives as cytotoxic and antiproliferative agents C Sanmartín, D Plano, E Domínguez, M Font, A Calvo, C Prior, I Encío, ... Molecules 14 (9), 3313-3338, 2009 | 70 | 2009 |
| Novel potent organoselenium compounds as cytotoxic agents in prostate cancer cells D Plano, C Sanmartín, E Moreno, C Prior, A Calvo, JA Palop Bioorganic & medicinal chemistry letters 17 (24), 6853-6859, 2007 | 65 | 2007 |
| Innovative lead compounds and formulation strategies as newer kinetoplastid therapies S Espuelas, D Plano, P Nguewa, M Font, JA Palop, JM Irache, ... Current medicinal chemistry 19 (25), 4259-4288, 2012 | 54 | 2012 |
| The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity E Ibanez, A Agliano, C Prior, P Nguewa, M Redrado, I Gonzalez-Zubeldia, ... Current medicinal chemistry 19 (18), 3031-3043, 2012 | 54 | 2012 |
| Novel seleno-and thio-urea derivatives with potent in vitro activities against several cancer cell lines V Alcolea, D Plano, DN Karelia, JA Palop, S Amin, C Sanmartin, ... European Journal of Medicinal Chemistry 113, 134-144, 2016 | 52 | 2016 |
| Antileishmanial activity of imidothiocarbamates and imidoselenocarbamates D Moreno, D Plano, Y Baquedano, A Jiménez-Ruiz, J Antonio Palop, ... Parasitology research 108, 233-239, 2011 | 52 | 2011 |
| Cells, materials, and fabrication processes for cardiac tissue engineering P Montero, M Flandes-Iparraguirre, S Musquiz, M Pérez Araluce, D Plano, ... Frontiers in Bioengineering and Biotechnology 8, 955, 2020 | 51 | 2020 |
